End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.5 TWD | -1.50% | +0.38% | -14.08% |
May. 03 | CHC Healthcare Group Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | CHC Healthcare Group Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 4.34B 134M | Sales 2025 * | - | Capitalization | 8.75B 271M |
---|---|---|---|---|---|
Net income 2024 * | 566M 17.55M | Net income 2025 * | 717M 22.23M | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
15.4
x | P/E ratio 2025 * |
12.2
x | Employees | - |
Yield 2024 * |
5.18% | Yield 2025 * |
-
| Free-Float | 59.89% |
1 day | -1.50% | ||
1 week | +0.38% | ||
Current month | -5.58% | ||
1 month | -5.58% | ||
3 months | -14.63% | ||
6 months | -14.63% | ||
Current year | -14.08% |
Managers | Title | Age | Since |
---|---|---|---|
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Yi Chun Chen
DFI | Director of Finance/CFO | - | 11-01-31 |
Ming Lun Lee
COO | Chief Operating Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yung Shun Chuang
BRD | Director/Board Member | - | 14-06-16 |
Pei Lin Lee
CEO | Chief Executive Officer | - | 09-11-24 |
Kuei Tuan Chen
BRD | Director/Board Member | - | 12-01-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 52.5 | -1.50% | 381,771 |
24-05-20 | 53.3 | +1.91% | 497,932 |
24-05-17 | 52.3 | +0.38% | 409,556 |
24-05-16 | 52.1 | -0.57% | 487,228 |
24-05-15 | 52.4 | +0.19% | 332,575 |
End-of-day quote Taiwan S.E., May 20, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.08% | 275M | |
+5.27% | 191M | |
+26.13% | 77.74M |
- Stock Market
- Equities
- 4164 Stock